New atypical antipsychotic for schizophrenia has ‘negligible’ weight effect


Go red for women: young woman jogging outdoors

A new atypical antipsychotic medication that provides a sustained improvement of the symptoms of schizophrenia with negligible effect on patients’ metabolic parameters has been welcomed by Australian experts.



This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?

Previous Pharmacists need to prepare consumers on PBS delisting: Demarte
Next Industry urged to coordinate on health insurance review: Sclavos

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.